Int J Stomatol

Inter J Stomatol ›› 2015, Vol. 42 ›› Issue (3): 273-275.doi: 10.7518/gjkq.2015.03.007

Previous Articles     Next Articles

Clinical and pathological analysis on submucous fibrosis coexisting with oral leukoplakia on 74 patients

Xiao Xuan, Wu Yingfang, Peng Jieying, Xie Di, Li Min, Song Xuelong   

  1. Dept. of Stomatology, Xiangya Hospital, Central South University, Changsha 410008, China
  • Received:2014-06-12 Revised:2015-02-10 Online:2015-05-01 Published:2015-05-01

RichHTML

4

PDF (PC)

1100

Abstract:

Objective The objective of this study is to observe the clinical and pathological characteristics of oral submucous fibrosis(OSF) coexisting with oral leukoplakia(OLK) to analyze the relationship between the degree of epithelial hyperplasia and the severity of fibrosis. Methods The clinical and pathological data of 74 patients with OSF coexisting with OLK were collected and reviewed. Results Seventy-four patients with OSF coexisting with OLK were mainly young and middle-aged male patients. All had the habit of chewing betel quid, and all exhibited symptoms of OSF and OLK, but higher prevalence is observed in age range of 20 to 49. Pathological features include widened epithelial cell gap, thickened basement membrane, and degenerated collagen fibers. Conclusion No relationship was found between the degree of epithelial hyperplasia and the severity of fibrosis in patients with OSF coexisting with OLK. OSF coexisting with OLK is not simply a combination of two diseases; rather, the combination of which has peculiar features.

Key words: oral submucous fibrosis, oral leukoplakia, coexistence

CLC Number: 

  • R 781.5

TrendMD: 
[1] Li Zheru,Dan Hongxia,Chen Qianming. Treatment of verrucous leukoplakia recurred after surgical excision using photodynamic therapy: a case report [J]. Int J Stomatol, 2021, 48(3): 318-321.
[2] Qun Li,Weiqun Guan,Yang’an Zhang,Zhichao. Huang. Expression of periostin and p53 in oral leukoplakia and oral squamous cell carcinoma [J]. Inter J Stomatol, 2019, 46(1): 5-11.
[3] Liu Jinli, Chen Fangman, Jiang Lu.. Drug management of oral submucous fibrosis [J]. Inter J Stomatol, 2017, 44(3): 325-331.
[4] Song Xuelong, Wei Gaoxing, Wu Yingfang, Peng Jieying, Liu Gengxun. Expressions of S100A7 in oral submucous fibrosis before and after treatment [J]. Inter J Stomatol, 2015, 42(5): 548-552.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[7] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[8] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[9] . [J]. Foreign Med Sci: Stomatol, 2004, 31(02): 126 -128 .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .